A generic alternative indicated for Asthma & Breathing. This clinical formulation provides dual-action relief by reducing localized swelling while relaxing muscular constriction in the airways.
A combination maintenance inhaler intended to manage asthma and COPD symptoms and developed to alleviate airway constriction to support long-term lung function.
Mechanism of Action
Budesonide reduces airway inflammation. Formoterol is a long-acting beta-2 agonist that relaxes the bronchial smooth muscle to keep airways open for 12 hours.
Route of Administration
Inhalation
Onset Time
15 minutes (bronchodilation)
Duration
12 hours
Contraindications
Allergy to any component, Severe milk protein allergy (DPI form)
Severe Adverse Events
Paradoxical bronchospasm, Pneumonia in COPD, Glaucoma/Cataracts, Adrenal suppression
Information for Budesonide Formoterol Inhaler is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
